PMC:7456203 / 2281-2638 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T14","span":{"begin":57,"end":64},"obj":"Body_part"},{"id":"T15","span":{"begin":241,"end":246},"obj":"Body_part"}],"attributes":[{"id":"A14","pred":"fma_id","subj":"T14","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A15","pred":"fma_id","subj":"T15","obj":"http://purl.org/sig/ont/fma/fma50801"}],"text":"CT-positive patients had significantly higher C-reactive protein (173.4 vs. 64 mg/L, p = 0.002) and elevated D-dimer (2.96 vs. 1.54 µg/mL, p = 0.018) than CT-negative patients. Moreover, a significantly lower PaO2/FIO2 ratio was observed in brain CT-positive patients (116 vs. 161, p = 0.033) (see Electronic Supplementary Material, e-Table 1 and e-Fig. 1)."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T15","span":{"begin":241,"end":246},"obj":"Body_part"}],"attributes":[{"id":"A15","pred":"uberon_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/UBERON_0000955"}],"text":"CT-positive patients had significantly higher C-reactive protein (173.4 vs. 64 mg/L, p = 0.002) and elevated D-dimer (2.96 vs. 1.54 µg/mL, p = 0.018) than CT-negative patients. Moreover, a significantly lower PaO2/FIO2 ratio was observed in brain CT-positive patients (116 vs. 161, p = 0.033) (see Electronic Supplementary Material, e-Table 1 and e-Fig. 1)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T33","span":{"begin":187,"end":188},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T34","span":{"begin":241,"end":246},"obj":"http://purl.obolibrary.org/obo/UBERON_0000955"},{"id":"T35","span":{"begin":241,"end":246},"obj":"http://www.ebi.ac.uk/efo/EFO_0000302"},{"id":"T36","span":{"begin":269,"end":272},"obj":"http://purl.obolibrary.org/obo/CLO_0001046"}],"text":"CT-positive patients had significantly higher C-reactive protein (173.4 vs. 64 mg/L, p = 0.002) and elevated D-dimer (2.96 vs. 1.54 µg/mL, p = 0.018) than CT-negative patients. Moreover, a significantly lower PaO2/FIO2 ratio was observed in brain CT-positive patients (116 vs. 161, p = 0.033) (see Electronic Supplementary Material, e-Table 1 and e-Fig. 1)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":57,"end":64},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"CT-positive patients had significantly higher C-reactive protein (173.4 vs. 64 mg/L, p = 0.002) and elevated D-dimer (2.96 vs. 1.54 µg/mL, p = 0.018) than CT-negative patients. Moreover, a significantly lower PaO2/FIO2 ratio was observed in brain CT-positive patients (116 vs. 161, p = 0.033) (see Electronic Supplementary Material, e-Table 1 and e-Fig. 1)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T15","span":{"begin":0,"end":176},"obj":"Sentence"},{"id":"T16","span":{"begin":177,"end":357},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"CT-positive patients had significantly higher C-reactive protein (173.4 vs. 64 mg/L, p = 0.002) and elevated D-dimer (2.96 vs. 1.54 µg/mL, p = 0.018) than CT-negative patients. Moreover, a significantly lower PaO2/FIO2 ratio was observed in brain CT-positive patients (116 vs. 161, p = 0.033) (see Electronic Supplementary Material, e-Table 1 and e-Fig. 1)."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T3","span":{"begin":100,"end":116},"obj":"Phenotype"}],"attributes":[{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0033106"}],"text":"CT-positive patients had significantly higher C-reactive protein (173.4 vs. 64 mg/L, p = 0.002) and elevated D-dimer (2.96 vs. 1.54 µg/mL, p = 0.018) than CT-negative patients. Moreover, a significantly lower PaO2/FIO2 ratio was observed in brain CT-positive patients (116 vs. 161, p = 0.033) (see Electronic Supplementary Material, e-Table 1 and e-Fig. 1)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"52","span":{"begin":46,"end":64},"obj":"Gene"},{"id":"53","span":{"begin":12,"end":20},"obj":"Species"},{"id":"54","span":{"begin":167,"end":175},"obj":"Species"},{"id":"55","span":{"begin":259,"end":267},"obj":"Species"}],"attributes":[{"id":"A52","pred":"tao:has_database_id","subj":"52","obj":"Gene:1401"},{"id":"A53","pred":"tao:has_database_id","subj":"53","obj":"Tax:9606"},{"id":"A54","pred":"tao:has_database_id","subj":"54","obj":"Tax:9606"},{"id":"A55","pred":"tao:has_database_id","subj":"55","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"CT-positive patients had significantly higher C-reactive protein (173.4 vs. 64 mg/L, p = 0.002) and elevated D-dimer (2.96 vs. 1.54 µg/mL, p = 0.018) than CT-negative patients. Moreover, a significantly lower PaO2/FIO2 ratio was observed in brain CT-positive patients (116 vs. 161, p = 0.033) (see Electronic Supplementary Material, e-Table 1 and e-Fig. 1)."}